These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33559186)

  • 1. Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol).
    Roggenkamp D; Dlova N; Mann T; Batzer J; Riedel J; Kausch M; Zoric I; Kolbe L
    Int J Cosmet Sci; 2021 Jun; 43(3):292-301. PubMed ID: 33559186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.
    Philipp-Dormston WG; Vila Echagüe A; Pérez Damonte SH; Riedel J; Filbry A; Warnke K; Lofrano C; Roggenkamp D; Nippel G
    Int J Cosmet Sci; 2020 Aug; 42(4):377-387. PubMed ID: 32390164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiamidol
    Roggenkamp D; Sammain A; Fürstenau M; Kausch M; Passeron T; Kolbe L
    J Dermatol; 2021 Dec; 48(12):1871-1876. PubMed ID: 34676600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural dynamics and susceptibility of isobutylamido thiazolyl resorcinol (Thiamidol
    Mahalapbutr P; Nuramrum N; Rungrotmongkol T; Kongtaworn N; Sabuakham S
    J Biomol Struct Dyn; 2023; 41(21):11810-11817. PubMed ID: 36644799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
    J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isobutylamido thiazolyl resorcinol for prevention of UVB-induced hyperpigmentation.
    Vachiramon V; Kositkuljorn C; Leerunyakul K; Chanprapaph K
    J Cosmet Dermatol; 2021 Mar; 20(3):987-992. PubMed ID: 32757247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
    Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
    J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation: A randomized, controlled trial.
    Vachiramon V; Sakpuwadol N; Yongpisarn T; Anuntrangsee T; Palakornkitti P
    J Cosmet Dermatol; 2024 Jul; 23(7):2450-2457. PubMed ID: 38497328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a wound-dressing biomaterial on prevention of postinflammatory hyperpigmentation after suction blister epidermal grafting in stable vitiligo patients: a controlled assessor-blinded clinical study with in vitro bioactivity investigation.
    Liu Z; Jiang M; Zhao J; Wang Q; Zhang C; Gao M; Gu M; Xiang L
    Arch Dermatol Res; 2020 Nov; 312(9):635-645. PubMed ID: 32107629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action.
    Kang M; Park SH; Park SJ; Oh SW; Yoo JA; Kwon K; Kim J; Yu E; Cho JY; Lee J
    Phytomedicine; 2019 May; 58():152877. PubMed ID: 30849679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment for postinflammatory hyperpigmentation: a systematic review.
    Tan MG; Kim WB; Jo CE; Nabieva K; Kirshen C; Ortiz AE
    J Dermatolog Treat; 2022 Aug; 33(5):2518-2526. PubMed ID: 34525885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
    Won YK; Loy CJ; Randhawa M; Southall MD
    Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists.
    Chandra M; Levitt J; Pensabene CA
    Acta Derm Venereol; 2012 May; 92(3):232-5. PubMed ID: 22002814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical applications of tyrosinases and tyrosinase inhibitors.
    Pisano L; Turco M; Supuran CT
    Enzymes; 2024; 56():261-280. PubMed ID: 39304289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined isobutylamido thiazolyl resorcinol and low-fluence Q-switched Nd: YAG laser for the treatment of facial hyperpigmentation: A randomized, split-face study.
    Vachiramon V; Leerunyakul K; Kositkuljorn C; Chayavichitsilp P
    J Cosmet Dermatol; 2021 Jun; 20(6):1724-1731. PubMed ID: 33118677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 4-amino-2',4'-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells.
    Lazinski LM; Beaumet M; Roulier B; Gay R; Royal G; Maresca M; Haudecoeur R
    Eur J Med Chem; 2024 Feb; 266():116165. PubMed ID: 38262119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
    Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
    Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East.
    Abanmi A; Al-Enezi M; Al Hammadi A; Galadari I; Kibbi AG; Zimmo S
    J Dermatolog Treat; 2019 Sep; 30(6):578-581. PubMed ID: 30426810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.